BIOEMTECH
Efthimis Lamprou is a seasoned professional in biomedical and medical engineering, currently serving as Chief Technology Officer at BIOEMTECH since September 2021. Prior to this role, Lamprou gained extensive experience as a Research Associate at the Institute of Instrumentation in Molecular Imaging, focusing on advanced imaging technologies such as gamma detectors and Time-Of-Flight PET. Additional expertise includes serving as an R&D Engineer at Oncovision, where responsibilities included the development of clinical and pre-clinical systems, and as a Trainee Research Developer at NCSR "DEMOKRITOS," contributing to the design of data acquisition systems for gamma imaging. Lamprou's academic credentials consist of a Doctorate from Universitat Politècnica de València, a Master's degree from the University of Valencia, and a Bachelor's degree in Physics from the University of Patras.
This person is not in any teams
This person is not in any offices
BIOEMTECH
BIOEMTECH is a preclinical CRO that aims to bridge the gap between ex vivo studies and in vivo molecular imaging, by providing cost effective solutions in terms of instrumentation and services. BIOEMTECH has developed and commercialized the "eyes", the first desktop cameras, suitable for whole body, real time imaging of PET and SPECT isotopes in mice. In addition, BIOEMTECH undertakes full studies for evaluating new compounds in our authorized laboratories that include animal facility, in vitro lab, radiochemistry lab and in vivo imaging with microPET/SPECT/CT and optical imaging. Our clients include both Universities and Pharma companies. The company is GLP accredited for pwrforming Toxicological studies and is licensed to use radioisotopes, hence capable of evaluating diagnostic and therapeutic radiopharmaceuticals. Finally, BIOEMTECH is rather active as an imaging partner in several projects including H2020, FET, ERA, ITN and more.